Moshe Oren

69.6k citations

323 papers · 48.9k indexed · 17 hit papers · h-index 116

Impact in

Oncology top 0.01%
- Cancer-related Molecular Pathways
Biotechnology top 0.01%
- Cancer Research and Treatments

Papers in

Biotechnology 75
- Cancer Research and Treatments 75
Oncology 214
- Cancer-related Molecular Pathways 198

Co-authors: Arnold J. Levine Ygal Haupt Ruth Maya Varda Rotter Dan Michalovitz Yaacov Barak Daniel Eliyahu Tanya Gottlieb
Journals: Molecular and Cellular Biology (35 papers)Oncogene (26 papers)Proceedings of the National Academy of Sciences (22 papers)Cell Death and Differentiation (16 papers)Molecular Cell (14 papers)
Partner nations: Israel United States Germany

In The Last Decade

Moshe Oren

323 papers receiving 47.7k citations

Hit Papers

15 papers align trajectories log scale

Drugging p53 in cancer: one protein, many targets 2022 · 410 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Reviews Drug Discovery
2013 Cancer Cell
2011 Genes & Cancer
2009 Cold Spring Harbor Perspectives in Biology
2009 Nature reviews. Cancer
2007 Molecular Cell
2003 Cell Death and Differentiation
2002 Seminars in Cancer Biology
2001 Genes & Development
1998 The Journal of Experimental Medicine
1997 Nature
1993 The EMBO Journal
1991 Nature
1990 Cell
1989 Proceedings of the National Academy of Sciences
1988 Molecular and Cellular Biology
1984 Nature

Peers

Countries citing papers authored by Moshe Oren

Since Specialization

Citations

This map shows the geographic impact of Moshe Oren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Oren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Oren more than expected).

Fields of papers citing papers by Moshe Oren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe Oren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Oren. The network helps show where Moshe Oren may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Moshe Oren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Moshe Oren Line = papers co-authored together Moshe Oren links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells Proceedings of the National Academy of Sciences ·Ori Hassin, Sara Öhman, Lina Leggire, Felix C. E. Vogel, Max D. Wellenstein, 坂本さつき, Coral Halperin, Rifan Fauzi, Julián A. Durand-González, Arkadiusz Ral Trebacz, Lisa Schlicker, Tomer‐Meir Salame, И. И. Мухаметгалиев, Yael Aylon, Ruth Scherz‐Shouval, Tamar Geiger, Karin E. de Visser, Almut Schulze, Moshe Oren	2023	6
2	Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis Nature Communications ·Yael Aylon, Noa Furth, Giuseppe Mallel, Gilgi Friedlander, Nishanth Belugali Nataraj, Meng Dong, Ori Hassin, 곽훈성, Benjamin Cohen, Vanessa Drendel, Tomer Meir Salame, Saptaparna Mukherjee, Nofar Harpaz, Randy L. Johnson, Walter E. Aulitzky, Yosef Yarden, Efrat Shema, Moshe Oren	2022	5
3	TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment Proceedings of the National Academy of Sciences ·Satish Kumar Satti, Giuseppe Mallel, Nishanth Belugali Nataraj, Michal Shreberk‐Shaked, Ori Hassin, Saptaparna Mukherjee, Sharathchandra Arandkar, Ron Rotkopf, Walter Zidek, Shuojie Gao, Lee Dou Young, James M. Beard, Ofra Golani, Yoseph Addadi, Emma Hajaj, Raya Eilam, Ravid Straussman, Yosef Yarden, Michal Lotem, Moshe Oren	2021	72
4	A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer Cancer Research ·Michal Shreberk‐Shaked, Bareket Dassa, Sanju Sinha, Silvia Di Agostino, Ido Azuri, Saptaparna Mukherjee, Yael Aylon, Giovanni Blandino, Eytan Ruppin, Moshe Oren	2020	50
5	Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer Cancer Research ·Jagmohan Hooda, Marián Novak, Matthew P. Salomon, Chikako Matsuba, Romela Irene Ramos, Emily MacDuffie, Ю.О. Молчанова, Michelle S. Hirsch, Jenny Lester, Vinita Parkash, Beth Y. Karlan, Moshe Oren, Dave S.�B. Hoon, Ronny Drapkin	2018	40
6	PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma Oncogene ·Eric Webster, Ali Mohammednour Ali Mohammed, ایمان سعد, Wayne Dillner, 尤睿, T. McCown, 三千夫駒井, Débora Rosa Bublik, Sarit Aviel‐Ronen, Keren Levanon, Edmond Sabo, Sarit Larisch, Moshe Oren, Dov Hershkovitz, Ruth Perets	2018	35
7	Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4 Cancer Research ·Matthias Gutekunst, Thomas Mueller, Tsuyoshi Itokawa, Michael A. Dengler, Jens Bedke, Stephan Kruck, Moshe Oren, Walter E. Aulitzky, Heiko van der Kuip	2013	47
8	Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin Cancer Research ·Hayder Tirmazi, Meng Dong, Trupti Patil Bhole Patil Bhole, Godehard Friedel, 泰治藤崎, Andreas Grabner, German Ott, Thomas E. Mürdter, Moshe Oren, Walter E. Aulitzky, Heiko van der Kuip	2012	24
9	Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress Proceedings of the National Academy of Sciences ·Slađana Bursać, Maja Cokarić Brdovčak, Martin Pfannkuchen, Ines Oršolić, Lior Golomb, Yan Zhu, Chen Katz, LIONEL WHITEY, Kristina Grabušić, Iva Vukelić, Vedrana Filić, Moshe Oren, Carol Prives, Siniša Volarević	2012	173
10	p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner Cancer Research ·Yoseph Addadi, Neta Moskovits, Dorit Granot, Guillermina Lozano, Yaron Carmi, Ron N. Apte, Michal Neeman, Moshe Oren	2010	88
11	Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity Cancer Research ·Samah Muaid Mawla, Moshe Oren, M. Lippmann, Matthias Gutekunst, Walter E. Aulitzky, Heiko van der Kuip	2009	19
12	Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2 Proceedings of the National Academy of Sciences ·Yoshinori Abe, Yangfu Li, Kei Tobiume, Keiko Kawauchi, Yoichi Taya, Koji Okamoto, Moshe Oren, Nobuyuki Tanaka	2008	113
13	Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells Cancer Research ·Lilach Weisz, Alexander Damalas, Michalis Liontos, Panagiotis Karakaidos, Giulia Fontemaggi, Revital Maor-Aloni, Deo Migadde, Massimo Levrero, Sabrina Strano, Vassilis G. Gorgoulis, Varda Rotter, Giovanni Blandino, Moshe Oren	2007	170
14	hTERT-Immortalized Prostate Epithelial and Stromal-Derived Cells: an Authentic In vitro Model for Differentiation and Carcinogenesis Cancer Research ·Ira Kogan, Naomi Goldfinger, Michael Milyavsky, Merav Cohen, Igor Shats, Gerhard Dobler, Helmut Klocker, Bohdan Wasylyk, Maureen Völler, Tilly Aalders, Jack A. Schalken, Moshe Oren, Varda Rotter	2006	86
15	p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. PubMed ·Ygal Haupt, Sheldon Rowan, Moshe Oren	1995	118
16	Identification of a Minimal Transforming Domain of p53: Negative Dominance through Abrogation of Sequence-Specific DNA Binding Molecular and Cellular Biology ·Eitan Shaulian, Arie Zauberman, Doron Ginsberg, Moshe Oren	1992	105
17	Stabilization of the p53 Transformation-Related Protein in Mouse Fibrosarcoma Cell Lines: Effects of Protein Sequence and Intracellular Environment Molecular and Cellular Biology ·Orna Halevy, Vivian Kuang Sheng, Moshe Oren	1989	16
18	Activating Mutations for Transformation by p53 Produce a Gene Product That Forms an hsc70-p53 Complex with an Altered Half-Life Molecular and Cellular Biology ·Cathy A. Finlay, Philip W. Hinds, Tse‐Hua Tan, Daniel Eliyahu, Moshe Oren, Arnold J. Levine	1988	283
19	Abelson Murine Leukemia Virus-Transformed Cells That Lack p53 Protein Synthesis Express Aberrant p53 mRNA Species Molecular and Cellular Biology ·D. Wolf, Gabriela Vörösová, Moshe Oren, Varda Rotter	1984	15
20	Two Distinct Mechanisms Regulate the Levels of a Cellular Tumor Antigen, p53 Molecular and Cellular Biology ·Nancy C. Reich, Moshe Oren, Arnold J. Levine	1983	98

About Moshe Oren

Moshe Oren is a scholar working on Biotechnology, Oncology, Cancer Research, Molecular Biology and Cell Biology, having authored 323 papers that have together received 48.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (198 papers), Cancer Research and Treatments (75 papers), RNA modifications and cancer (48 papers), Ubiquitin and proteasome pathways (47 papers), Epigenetics and DNA Methylation (45 papers), Virus-based gene therapy research (34 papers), Cell death mechanisms and regulation (28 papers) and RNA Research and Splicing (24 papers). The work is most often cited by research in Oncology (28.8k citations), Biotechnology (7.2k citations), Cancer Research (9.9k citations), Molecular Biology (34.9k citations) and Cell Biology (4.1k citations). Moshe Oren has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Arnold J. Levine, Ygal Haupt, Ruth Maya, Varda Rotter, Dan Michalovitz, Yaacov Barak, Daniel Eliyahu, Tanya Gottlieb, Dan Michael and Yael Aylon. Their work appears in journals such as Molecular and Cellular Biology, Oncogene, Proceedings of the National Academy of Sciences, Cell Death and Differentiation and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact